Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study showsSeptember 05, 2007The results of a clinical trial, published in late August in the Journal of Pediatrics, indicates that, when used as part of routine therapy, high-dose ibuprofen is safe, and effective in slowing down lung disease in children with cystic fibrosis (CF). Headed by Dr. Larry Lands, Director of Pediatric Respiratory Medicine at Montreal Children's Hospital of the McGill University Health Centre, the multi-centre study monitored 142 children aged six to 18 with mild lung disease over two years. Children given high-dose ibuprofen twice a day showed a significant reduction in the rate of decline in lung function, and had fewer and shorter hospital stays.
"Slowing the rate of the decline of lung function will result in enhanced longevity and quality of life for patients with CF," said Dr. Larry Lands. "Many treatments for cystic fibrosis can be a financial hardship for families," said Cathleen Morrison, Chief Executive Officer at the Canadian Cystic Fibrosis Foundation. "News that ibuprofen - a relatively inexpensive treatment compared to other therapies for CF - is effective, is very exciting." "We are delighted to share this great news. The findings of this study show that through research and innovation, a simple inexpensive treatment can have a profound impact on the lives of children affected by CF and their families," said Dr. Peter Liu, Scientific Director of CIHR's Institute of Circulatory and Respiratory Health. McGill University Health Centre | |||||||||||||||||||||
|
Related Ibuprofen Current Events and Ibuprofen News Articles First international guidelines for treatment of psoriatic arthritis Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it. Common painkillers lower levels of prostate cancer biomarker Common painkillers like aspirin and ibuprofen appear to lower a man's PSA level, the blood biomarker widely used by physicians to help gauge whether a man is at risk of prostate cancer. Anti-inflammatory drugs may mask prostate cancer marker Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirin and ibuprofen, may reduce serum levels of the prostate biomarker, PSA (prostate specific antigen), and hence may alter the detection of prostate cancer in individuals who take these medications. Over-the-counter anesthetic gel puts the squeeze on mammogram pain The simple application of a pain-relieving gel may reduce the breast discomfort some women experience during mammography exams, according to the results of a clinical trial published in the online edition of Radiology. Some antidepressants associated with gastrointestinal bleeding A class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs) appear to be associated with bleeding in the upper gastrointestinal tract. Anti-inflammatory drug blocks brain plaques Brain destruction in Alzheimer's disease is caused by the build-up of a protein called amyloid beta in the brain, which triggers damaging inflammation and the destruction of nerve cells. Common bowel problem linked to chili pepper pain receptor People with irritable bowel syndrome have a higher than usual number of chilli pepper pain receptors, according to a new study published tomorrow (Wednesday 11 June). Premature tooth loss can affect oral health for years to come The prospect of exchanging a tooth for that coveted reward from the tooth fairy often has kids wiggling teeth with vigor, but what happens when a primary or permanent tooth is lost prematurely due to trauma? Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial Celecoxib, the anti-inflammatory medication also known by the trade name Celebrex, has proven to be safe and reduces a specific proliferation measurement of precancerous lesions in the lung, according to a study from The University of Texas M. D. Anderson Cancer Center. Ibuprofen or acetaminophen in long-term resistance training increases muscle mass/strength Taking daily recommended dosages of ibuprofen and acetaminophen caused a substantially greater increase over placebo in the amount of quadriceps muscle mass and muscle strength gained during three months of regular weight lifting, in a study by physiologists at the Human Performance Laboratory, Ball State University. More Ibuprofen Current Events and Ibuprofen News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||